GlucoSentient, Inc.

Basic Information

60 Hazelwood Drive
Champaign, IL, 61820-0000

Point of Contact Information

Field Value
Business Official:
Firm CFO (or equivalent):
POC Contracting Officer (or equivalent)

Additional Details

Field Value
SBC Control ID:
DUNS: 78305396
CAGE: n/a
SIC Codes: n/a
NAICS Codes: n/a

Company Profile


  1. SBIR Phase II: A Novel Device for Convenient Therapeutic Drug Monitoring of Tacrolimus

    Amount: $750,000.00

    This Small Business Innovation Research (SBIR) Phase II project is aiming to develop and validate a point-of-care monitoring for tacrolimus, an immunosuppressive medication widely used by organ transp ...

    SBIR Phase II 2013 National Science Foundation
  2. SBIR Phase I: Novel Biosensor for Monitoring of Theophylline using Personal Glucose Meter

    Amount: $149,999.00

    This Small Business Innovation Research Phase I project aims to develop a new technology to utilize ubiquitous personal glucose meters (PGMs) for inexpensive and convenient at-home tests of the drug t ...

    SBIR Phase I 2012 National Science Foundation

Agency Micro-sites

SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government